---
title: "Aclarion, Inc. (ACON.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ACON.US.md"
symbol: "ACON.US"
name: "Aclarion, Inc."
industry: "Health Care Technology"
---

# Aclarion, Inc. (ACON.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Location | US Market |
| Website | [www.aclarion.com](https://www.aclarion.com) |

## Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of inter...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:12.000Z

**Overall: C (0.49)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 30 / 47 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 36.91% |  |
| Net Profit YoY | -17.63% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.22 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.72M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 67483.00 |  |


**Multi Score**: C

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -98.44% | E |
| Profit Margin | -10868.01% | E |
| Gross Margin | 23.15% | D |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 36.91% | A |
| Net Profit YoY | -17.63% | D |
| Total Assets YoY | 314.06% | A |
| Net Assets YoY | 398.07% | A |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -0.91% | D |
| OCF YoY | 36.91% | A |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.01 | E |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 5.30% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Aclarion, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-98.44%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-10868.01%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "23.15%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "36.91%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-17.63%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "314.06%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "398.07%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-0.91%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "36.91%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.01",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "5.30%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B |
| 02 | Doximity (US.DOCS) | A | B | C | A | C | B |
| 03 | Waystar (US.WAY) | C | B | D | B | B | B |
| 04 | Phreesia (US.PHR) | C | B | A | B | D | B |
| 05 | HealthStream (US.HSTM) | B | C | B | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.37 | 13/42 | - | - | - |
| PB | 0.22 | 2/42 | 0.37 | 0.31 | 0.26 |
| PS (TTM) | 40.31 | 36/42 | 81.17 | 70.96 | 56.87 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-20T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.58 |
| Highest Target | 23.00 |
| Lowest Target | 23.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/ACON.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ACON.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ACON.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.